NRAS Mutant
Showing 1 - 25 of 711
Melanoma Trial in Beijing (tunlametinib, paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin)
Not yet recruiting
- Melanoma
- tunlametinib
- paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Aug 15, 2023
Recurrent Rectal Cancer, Stage IIA Rectal Cancer, Stage IIB Rectal Cancer Trial in United States (trametinib, fluorouracil,
Active, not recruiting
- Recurrent Rectal Cancer
- +6 more
- trametinib
- +2 more
-
Saint Louis, Missouri
- +3 more
Feb 15, 2022
Locally Advanced or Metastatic NRAS Mutant Melanoma Trial in Worldwide (LEE011, MEK162)
Completed
- Locally Advanced or Metastatic NRAS Mutant Melanoma
-
San Francisco, California
- +16 more
Nov 23, 2020
BRAF or NRAS Mutant Metastatic Melanoma Trial in Worldwide (MEK162)
Active, not recruiting
- BRAF or NRAS Mutant Metastatic Melanoma
-
Fayetteville, Arkansas
- +20 more
Nov 18, 2021
NSCLC, Melanoma Trial in Worldwide (LXH254, LTT462, Trametinib)
Active, not recruiting
- Non-Small Cell Lung Cancer
- Melanoma
- LXH254
- +3 more
-
San Diego, California
- +31 more
Sep 12, 2022
Melanoma Trial in New York, Philadelphia (Trametinib daily Until PD, CDX-3379 (ERBB3 antibody))
Terminated
- Melanoma
- Trametinib daily Until PD
- CDX-3379 (ERBB3 antibody)
-
New York, New York
- +1 more
May 12, 2020
Stage IV Melanoma, Stage III Melanoma Trial in Jette (Trametinib, Dabrafenib)
Recruiting
- Stage IV Melanoma
- Stage III Melanoma
-
Jette, Brussels, BelgiumUniversitair Ziekenhuis Brussel
Sep 29, 2021
Solid Tumours, Multiple Myeloma, Lung Cancer Trial in Sutton, London (VS-6766, Everolimus)
Recruiting
- Solid Tumours
- +2 more
-
Sutton, Surrey, United Kingdom
- +1 more
Apr 25, 2022
NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in United States (RMC-6236)
Recruiting
- Non-small Cell Lung Cancer (NSCLC)
- +3 more
-
Boston, Massachusetts
- +9 more
Dec 22, 2022
Malignant Solid Tumor, Ovarian Low Grade Serous Adenocarcinoma, Pancreatic Carcinoma Trial (Binimetinib, Biopsy, Biospecimen
Not yet recruiting
- Malignant Solid Neoplasm
- +4 more
- Binimetinib
- +6 more
- (no location specified)
Nov 8, 2022
Solid Tumors With HRAS Alterations, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial (KO-2806, Cabozantinib)
Not yet recruiting
- Solid Tumors With HRAS Alterations
- +4 more
- (no location specified)
Aug 30, 2023
Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial in United States (DCC-3116, Trametinib, Binimetinib)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +5 more
- DCC-3116
- +3 more
-
Boston, Massachusetts
- +4 more
May 25, 2022
Colorectal Cancer, Pancreatic Cancer, Lung Cancer Trial in Brooklyn, New York (Vitamin C)
Recruiting
- Colorectal Cancer
- +2 more
- Vitamin C
-
Brooklyn, New York
- +1 more
Sep 22, 2021
Metastatic Colorectal Cancer Trial in United States (BAX69 + infusional 5-FU/LV, BAX69 + panitumumab, BAX69 + 5-FU/LV)
Terminated
- Metastatic Colorectal Cancer
- BAX69 + infusional 5-FU/LV
- +3 more
-
Port Saint Lucie, Florida
- +11 more
May 3, 2021
Unresectable or Metastatic BRAFV600E Mutant Melanoma Patients
Recruiting
- Melanoma (Skin)
- +2 more
-
Evora, PortugalHospital Evora
May 30, 2022
Cancer, Malignancy, Neoplasia Trial in United States (ASN007: ascending doses, ASN007 RD)
Completed
- Cancer
- +18 more
- ASN007: ascending doses
- ASN007 RD
-
Tampa, Florida
- +4 more
Jul 7, 2020